Legislative Impact - The failure to extend Affordable Care Act (ACA) subsidies is expected to lead to significantly higher monthly premiums for millions of enrollees starting in January [6][7] - The legislative deadlock occurred on a 51-48 vote, effectively ending Democratic efforts to prevent price hikes during the current session [5][6] Company Impact - Major health insurers, particularly those heavily exposed to ACA exchanges such as Centene Corp., Molina Healthcare Inc., and Oscar Health Inc., are expected to face headwinds due to the legislative impasse [7] - Hospital operators like HCA Healthcare Inc. and Tenet Healthcare Corp. may encounter increased risks, as a potential drop in coverage due to rising premiums could lead to a surge in uncompensated care and bad debt [8]

Core Insights - Molina Healthcare reported disappointing third-quarter results, leading to a decline in stock prices for Centene Corporation and Oscar Health Inc. [1] - The company’s adjusted earnings per share for Q3 were $1.84, significantly lower than $6.01 from the previous year and below the consensus estimate of $3.90 [1] Financial Performance - Molina Healthcare's consolidated medical care ratio (MCR) for Q3 2025 increased to 92.6%, up from 89.2% year-over-year [2] - The MCR breakdown includes 92.0% for Medicaid, 93.6% for Medicare, and 95.6% for Marketplace [2] Future Guidance - For fiscal 2025, Molina Healthcare expects adjusted earnings of $14 per share, lower than the consensus of $18.65 and previous guidance of over $19 [3] - The company raised its 2025 sales guidance from $44 billion to $44.5 billion, slightly above the consensus of $44.39 billion [3] Cost Trends - The updated guidance reflects higher medical cost trends across all segments, particularly in the Marketplace, which is anticipated to persist through the end of the year [4] - Molina forecasts a 2025 MCR of 91.3%, with specific expectations of 91.5% for Medicaid, 91.3% for Medicare, and 89.7% for Marketplace, compared to earlier expectations of 90.2% overall [4] Upcoming Earnings Reports - Centene is set to release its Q3 2025 financial results on October 29, with analysts estimating an adjusted loss of 14 cents and sales of $47.75 billion [5] - Oscar Health will report its Q3 2025 results on November 6, with an expected adjusted loss of 56 cents and sales of $3.08 billion [5] Market Reaction - Following Molina Healthcare's report, Oscar Health's stock fell by 9.74% to $18.39, while Centene's stock decreased by 6.61% [7]